Considering that their primary effect is mediated by inhibiting renal glucose absorption, provided that renal function (and thus glomerular filtration) is relatively preserved, these agents effect similar improvements in glycaemic control in newly diagnosed or longer duration T2D, irrespective of their degree of insulin sensitivity or residual insulin secretion [18]. Here, INS is linked to type 2 diabetes mellitus.